You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68Ga-NOTA-RM26

Showing 1 - 25 of 2,793
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Gastrointestinal Stromal Tumors Trial in Beijing (68Ga-NOTA-RM26)

Recruiting
  • Gastrointestinal Stromal Tumors
  • 68Ga-NOTA-RM26
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Aug 6, 2021

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)

Recruiting
  • Breast Cancer
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 18, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Healthy Volunteers Trial in Birmingham (CSB-111)

Recruiting
  • Healthy Volunteers
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 25, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • [68Ga]Ga-NOTA-SNA002
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)

Recruiting
  • Insulinoma
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 29, 2022

Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NOTA-AE105, PET/CT)

Completed
  • Neuroendocrine Tumors
  • One injection of 68Ga-NOTA-AE105
  • PET/CT
  • Copenhagen, Denmark
    Department of Clinical Physiology, Nuclear Medicine and PET, Rig
Jun 28, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Positron-Emission Tomography Trial in Fuzhou (68Ga-NOTA Evans Blue)

Recruiting
  • Positron-Emission Tomography
  • 68Ga-NOTA Evans Blue
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Nov 17, 2021

Insulinoma Trial in Beijing ([68Ga]Ga-HBED-CC-exendin-4, [68Ga]Ga-NOTA-exendin-4)

Recruiting
  • Insulinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 2, 2021

Prostate Cancer Trial in Milan (68Ga-PSMA, 68Ga-RM2)

Completed
  • Prostate Cancer
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Apr 5, 2023

Lymphoma Trial (68Ga-NOTA-RP25)

Not yet recruiting
  • Lymphoma
  • 68Ga-NOTA-RP25
  • (no location specified)
Dec 16, 2021

Prostate Cancer Trial in Stanford (68Ga RM2, 68Ga-PSMA-11, Investigational PET scanner coils and software)

Suspended
  • Prostate Cancer
  • 68Ga RM2
  • +2 more
  • Stanford, California
    Stanford University
May 3, 2022

Prostate Cancer Trial in Bordeaux (68Ga-PSMA-617 PET/CT, 68Ga-RM2 PET/CT)

Recruiting
  • Prostate Cancer
  • 68Ga-PSMA-617 PET/CT
  • 68Ga-RM2 PET/CT
  • Bordeaux, France
    Bordeaux University Hospital
Mar 29, 2022

Prostate Adenocarcinoma Trial in Palo Alto (Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging,

Active, not recruiting
  • Prostate Adenocarcinoma
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

Prostate Cancer Trial in Stanford (drug, device, procedure)

Suspended
  • Prostate Cancer
  • 68-Ga RM2
  • +3 more
  • Stanford, California
    Stanford University
May 3, 2022

Breast Carcinoma, Estrogen Receptor Positive Trial in Palo Alto (drug, procedure, device)

Suspended
  • Breast Carcinoma
  • Estrogen Receptor Positive
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Dec 8, 2021

Prostate Cancer Trial in New York (68Ga-RM2 (RM2), PET/CT Scan)

Completed
Has Results
  • Prostate Cancer
  • 68Ga-RM2 (RM2)
  • PET/CT Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 27, 2021

Fibrosis, Positron-Emission Tomography Trial in Fuzhou (68Ga-FAPI-04)

Recruiting
  • Fibrosis
  • Positron-Emission Tomography
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 1, 2021

Tumor, Positron-Emission Tomography, Metastasis Trial in Fuzhou (68Ga-DOTA/NOTA-FAPI-04, PET/CT scan)

Recruiting
  • Tumor
  • +2 more
  • Fuzhou, Fujian, China
    The First Affiliated Hospital of Fujian Medical University
Sep 5, 2020

Prostate Cancer Trial in Copenhagen (68Ga-NOTA-AE105)

Unknown status
  • Prostate Cancer
  • Copenhagen, Denmark
    Rigshospitalet
Nov 20, 2020